Global Cannabis Applications Corp. (CSE:APP, FWB:2FA, OTCQB: FUAPF), a leading developer of innovative data technologies for the cannabis industry, has signed a partnership agreement with the Blockchain Centre Vilnius (the “BC Centre”), the first blockchain technology centre connecting key stakeholders in Asia and Europe. The BC Centre is a technology hubconnecting blockchain investors, startups, and regulators to share know-how and best practices worldwide through its two partner centres in Melbourne, Australia, and Shanghai, China.
“Blockchain technology presents numerous opportunities for the healthcare and medical industries,” said Ms. Egle Nemeikstyte, Chief Executive Officer of the Blockchain Centre Vilnius. “Technologists and healthcare professionals across the globe recognize blockchain technology as the way to streamline the sharing of medical records in a secure, trusted way. Blockchain protects sensitive data from hackers and gives patients much more control over their own medical information. The Blockchain Centre Vilnius is very honoured to partner with GCAC – a global tech company pioneering innovative technology solutions for the medical cannabis industry by launching the end-to-end data aggregation and user delivery system. The partnership with GCAC is an excellent opportunity to show citizens, businesses and public administrators that blockchain technologies and applications go far beyond cryptocurrencies.”
“Lithuania is capitalising on its stable jurisdiction and early commitment to innovative blockchain technology and the potential legalization of medical cannabis,” said Brad Moore, Chief Executive Officer of GCAC. “Vilnius is a city with a world-class IT infrastructure, a multilingual talent pool, and access to the European marketplace of more than 500 million consumers. It has become a technology centre where great ideas turn into reality and where the blockchain industry finds IT talent and an extremely supportive tech community. These are the reasons that Lithuania was chosen to establish a European counterpart to Australia and China. GCAC will benefit from the intercontinental knowledge and talent sharing pool via the Blockchain Centre Vilnius.”
Lithuania has been steadily advancing the case for blockchain technology in finance, health, content sharing and public administration. According to the Bloomberg Innovation Index 2017, Lithuania is one of the world’s most innovative economies. The country is also ranked among the top 30 countries in doing Business Index by the World Bank. Furthermore, the prestigious American business magazine Forbes has ranked Lithuania 15th globally in its annual Best Countries for Business List. Lithuania recently instituted “start-up visa” that makes it easier to attract and retain top talent from non-EU countries. E-signatures are widely utilized and accepted, and onboarding takes place remotely via online video calls. Lithuania is number one in Europe in fibre-optic penetration and boasts one of the world’s fastest internet networks.
“As a hub dedicated to exceptional companies applying blockchain technology, the Blockchain Centre Vilnius incubates and accelerates blockchain start-ups while sharing information about new blockchain opportunities with investors and businesses alike. We believe, that the key to success in today’s world is to build a strong community and connecting it to the global network,” added Ms. Nemeikstyte.
About the Blockchain Center Vilnius
The Blockchain Centre Vilnius – member of Melbourne and Shanghai BC group – is the first blockchain technology centre connecting key stakeholders in Asia and Europe. Its goal is to unlock value using blockchain technology in business, finance and public administration. The BC Centre incubates and accelerates blockchain companies while sharing information about new blockchain opportunities with investors and businesses alike. The Blockchain Centre Vilnius is a physical hub located in a smart, energy efficient building in the capital of Lithuania. For more information about the Centre, please visit online at www.bcgateway.eu.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in medical cannabis. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-561-9091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Click here to connect with Global Cannabis Applications Corp. (CSE:APP, FWB:2FA, OTCQB: FUAPF) for an Investor Presentation

Source: www.thenewswire.com


PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to provide a corporate update on its psychedelic pharmaceuticals program. Since its inception, the Company has built a unique product pipeline for novel uses of ketamine, psilocybin and undisclosed psychedelics. PharmaTher is positioning itself to partner its psilocybin program and panaceAI™, and focus on advancing its novel ketamine product pipeline in Parkinson’s disease, depression and pain via the U.S. Food and Drug Administration (“FDA”) regulatory pathway.

“We have made tremendous progress over the last several months that saw our product pipeline evolve to focus on the massive opportunity and potential of ketamine, an FDA approved drug with a known safety profile, to treat significant unmet medical needs for Parkinson’s disease, depression and pain,” said Fabio Chianelli, CEO of PharmaTher. “With our focus on ketamine through repurposing, combining it with an FDA approved drug and delivering it with our novel microneedle delivery system, we are now positioned to expedite our clinical development objectives by taking advantage of the FDA’s 505(b)(2) regulatory pathway and commercializing disruptive ketamine treatments for mental health and pain disorders.”

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB)(TSX: ACB), and Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED).

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), an emerging leader in reducing the carbon footprint of cement products using natural pozzolans, is pleased to announce it has sold and optioned a combined total of 10 million of its 10.5 million shares of Snow Lake Resources.

The sale and option agreements were made with two arms-length purchasers. The first sale was for 1,700,000 shares at $0.04 per share for a total of $68,000 and includes an option granted by PLAN entitling the same party to purchase an additional 4,966,666 shares at $0.04 per share until May 11, 2021 . The second sale was for 1,250,000 shares at $0.04 per share for a total of $50,000 and includes an option granted by PLAN to such party to purchase an additional 2,083,334 shares until August 14, 2021 . As at the date of this news release, PLAN has received $116,000 and will receive another $284,000 if the remaining shares are purchased under the option agreements.

Keep reading... Show less

First Products to Hit California Shelves in Q2 2021

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that its fully funded state of the art 185,000 square foot production facility in Commerce, California is nearing completion and will be ready to serve the $3b California cannabis market in Q2 2021. The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May.

Keep reading... Show less

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders and prospective investors – by increasing awareness of its remarkable natural mustard-derived crop protection products.

TODAY: The Future of Food Investment Conference – SnowCap Ventures
Tuesday, Nov. 24th at 1:50 pm ET
Investors Register Here

Keep reading... Show less